Anstoß für neue Therapien

Diabetes mellitus is a widespread disease that requires continuous research and innovative approaches. The individual differences in response to treatments and the diversity of diabetes types make it a complex challenge. Clinical trials are key to developing more effective therapies and improved treatment approaches. In the field of diabetology, they enable the evaluation of new drugs, therapeutic approaches and technologies. Clinical trials help to confirm the safety and efficacy of interventions and improve the quality of life of people with diabetes.

The involvement of doctors in private practice in clinical trials is of crucial importance. These physicians are in direct contact with patients and understand their needs and challenges best. Their involvement ensures that the research is not only scientifically robust, but also reflects real-world patient care conditions.

With our network's diabetology-focused study sites, CROs and sponsors benefit from faster study start-up and higher patient retention due to the growing patient base of practicing diabetics.

4 study centers in our network
An average of 20 years of study experience
Over 150 clinical trials in the fields of diabetes and cardiovascular outcome studies
Studies

Diabetes studies with SIGAL SMS

• 4 study centers in our network
• An average of 20 years of study experience
• Over 150 clinical trials in the fields of diabetes and cardiovascular outcome studies
• Study phases II - IV
• 36.000 patients in data base